| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Merck E |
Merck MDMA Patent |
German Patent Office |
1914 |
| Roberts AS, Alexander F |
Report on Clinical Evaluation of SKF #5 (Amphedoxamine) [MDA] |
[Memo, 1957 Aug 21] |
1957 |
| Balestrieri A |
Psychotrope Pharmaka und psychische Epilepsie. Erfahrungen mit Weckam... |
Nervenarzt |
1959 |
| Kristensen KK |
Kliniske erfaringer med psilocybin |
Nord. psykiat. T. |
1963 |
| Jackson B, Reed A Jr |
Another Abusable Amphetamine |
JAMA |
1970 |
| Gaston TR, Rasmussen GT |
Identification of 3,4 methylenedioxymethamphetamine |
Bureau of Narcotics ... |
1972 |
| Sreenivasan VR |
Problems in Identification of Methylenediony and Methoxy Amphetamines |
Journal of Criminal ... |
1972 |
| Hardman HF, Haavik CO, Se... |
Relationship of the structure of mescaline and seven analogs to toxici... |
Toxicol Appl Pharmac... |
1973 |
| Turek IS, Soskin RA, Kurl... |
Methylenedioxyamphetamine (MDA) Subjective Effects |
Journal of Psychedel... |
1974 |
| Nichols DE, Ilhan M, Long... |
Comparison of Cardiovascular, Hyperthermic, and Toxic Effects of Para-... |
Arch Int de Pharmaco... |
1975 |
| Lopatka JE, Brewerton CN,... |
The protective effects of methysergide, 6-hydroxydopamine and other ag... |
Res Commun Chem Path... |
1976 |
| Yensen R, Di Leo FB, Rhea... |
MDA-assisted psychotherapy with neurotic outpatients: a pilot study |
J Nerv Ment Dis |
1976 |
| Anderson GM 3d, Braun G, ... |
Absolute configuration and psychotomimetic activity |
NIDA Res Monogr |
1978 |
| Shulgin AT, Nichols DE |
Characterization of three new psychotomimetics. The Pharmacology of Ha... |
The Psychopharmacolo... |
1978 |
| Poklis A, Mackell MA, Dra... |
Fatal intoxication from 3,4-methylenedioxyamphetamine |
J Forensic Sci |
1979 |
| Lukaszewski T |
3,4-methylenedioxyamphetamine overdose |
Clin Toxicol |
1979 |
| Strassman RJ, Galanter M |
The Abhidharma: a cross-cultural model for the psychiatric application... |
Int J Soc Psychiatry |
1980 |
| Braun U, Shulgin AT, Brau... |
Centrally active N-substituted analogs of 3,4- methylenedioxyphenyliso... |
J Pharm Sci |
1980 |
| O'Brien BA, Bonicamp JM, ... |
Differentiation of Amphetamine and Its Major Hallucinogenic Derivative... |
J Anal Toxicol |
1982 |
| Nichols DE, Lloyd DH, Hof... |
Effects of certain hallucinogenic amphetamine analogues on the release... |
J Med Chem |
1982 |
| Davis WM, Borne RF |
Pharmacologic investigation of compounds related to 3,4-methylenedioxy... |
Subst Alcohol Action... |
1984 |
| Ricaurte G, Bryan G, Stra... |
Hallucinogenic amphetamine selectively destroys brain serotonin nerve ... |
Science |
1985 |
| Gehlert DR, Schmidt CJ, W... |
Evidence for specific methylenedioxymethamphetamine (ecstasy) binding ... |
Eur J Pharmacol |
1985 |
| Mack RB |
A bit on the Wilde side: MDMA abuse |
N C Med J |
1985 |
| Riedlinger JE |
The scheduling of MDMA: a pharmacist's perspective |
J Psychoactive Drugs |
1985 |
| Ziporyn T |
A growing industry and menace: makeshift laboratory's designer drugs |
JAMA |
1986 |
| Seymour RB, Wesson DR, Sm... |
MDMA (3,4-methylenedioxymethamphetamine): proceedings of the conferenc... |
J Psychoactive Drugs |
1986 |
| Seymour RB, Wesson DR, Sm... |
Editor's Introduction |
J Psychoactive Drugs |
1986 |
| Beardsley PM, Balster RL,... |
Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus ... |
Drug Alcohol Depend |
1986 |
| Beck J |
MDMA: The popularization and resultant implications of a recently cont... |
Contemporary Drug Pr... |
1986 |
| Beck J, Morgan PA |
Designer drug confusion: a focus on MDMA |
J Drug Educ |
1986 |
| Brady JF, Di Stefano EW, ... |
Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphet... |
Life Sci |
1986 |
| Buffum J, Moser C |
MDMA and human sexual function |
J Psychoactive Drugs |
1986 |
| Climko RP, Roehrich H, Sw... |
Ecstacy: a review of MDMA and MDA |
Int J Psychiatry Med |
1986 |
| Commins DL, Vosmer G, Vir... |
Biochemical and histological evidence that methylenedioxymethylampheta... |
J Pharmacol Exp Ther |
1986 |
| Downing J |
The psychological and physiological effects of MDMA on normal voluntee... |
J Psychoactive Drugs |
1986 |
| Evans SM, Johanson CE |
Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamph... |
Drug Alcohol Depend |
1986 |
| Greer G, Tolbert R |
Subjective reports of the effects of MDMA in a clinical setting |
J Psychoactive Drugs |
1986 |
| Grinspoon L, Bakalar JB |
Can drugs be used to enhance the psychotherapeutic process? |
Am J Psychother |
1986 |
| Hayner GN, McKinney H |
MDMA. The dark side of ecstasy |
J Psychoactive Drugs |
1986 |
| Holsten DW, Schieser DW |
Controls over the manufacture of MDMA |
J Psychoactive Drugs |
1986 |
| Johnson MP, Hoffman AJ, N... |
Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... |
Eur J Pharmacol |
1986 |
| Kamien JB, Johanson CE, S... |
The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylene... |
Drug Alcohol Depend |
1986 |
| Leverant R |
MDMA reconsidered |
J Psychoactive Drugs |
1986 |
| Lyon RA, Glennon RA, Tite... |
3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions... |
Psychopharmacology (... |
1986 |
| Newmeyer JA |
Some considerations on the prevalence of MDMA use |
J Psychoactive Drugs |
1986 |
| Nichols DE |
Differences between the mechanism of action of MDMA, MBDB, and the cla... |
J Psychoactive Drugs |
1986 |
| Noggle FT Jr, DeRuiter J,... |
Spectrophotometric and liquid chromatographic identification of 3,4-me... |
J Assoc Off Anal Che... |
1986 |
| Renfroe CL |
MDMA on the street: Analysis Anonymous |
J Psychoactive Drugs |
1986 |
| Schechter MD |
Discriminative profile of MDMA |
Pharmacol Biochem Be... |
1986 |
| Schmidt CJ, Wu L, Lovenbe... |
Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine an... |
Eur J Pharmacol |
1986 |
| Shulgin AT |
The background and chemistry of MDMA |
J Psychoactive Drugs |
1986 |
| Siegel RK |
MDMA-Nonmedical use and intoxication |
J Psychoactive Drugs |
1986 |
| Stone DM, Stahl DC, Hanso... |
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... |
Eur J Pharmacol |
1986 |
| Wolfson PE |
Meetings at the edge with Adam: A man for all seasons? |
J Psychoactive Drugs |
1986 |
| Davis WM, Catravas JD, Wa... |
Effects of an i.v. lethal dose of 3,4-methylenedioxyamphetamine (MDA) ... |
Gen Pharmacol |
1986 |
| Callaway E |
The Biology of Human Information Processing |
J Psychoactive Drugs |
1986 |
| Battaglia G, Yeh SY, O'He... |
3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... |
J Pharmacol Exp Ther |
1987 |
| Boja JW, Schechter MD |
Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; 'EVE... |
Pharmacol Biochem Be... |
1987 |
| Brown C, Osterloh J |
Multiple severe complications from recreational ingestion of MDMA ('Ec... |
JAMA |
1987 |
| Davis WM, Hatoum HT, Wate... |
Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevan... |
Alcohol Drug Res |
1987 |
| Dowling GP, McDonough ET ... |
'Eve' and 'Ecstasy'. A report of five deaths associated with the use o... |
JAMA |
1987 |
| Frith CH, Chang LW, Latti... |
Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... |
Fundam Appl Toxicol |
1987 |
| Gibb JW, Stone DM, Stahl ... |
The effects of amphetamine-like designer drugs on monoaminergic system... |
NIDA Res Monogr |
1987 |
| Glennon RA, Little PJ, Ro... |
The effect of MDMA ('Ecstasy') and its optical isomers on schedule-con... |
Pharmacol Biochem Be... |
1987 |
| Kulmala HK, Boja JW, Sche... |
Behavioral suppression following 3,4-methylenenedioxymethamphetamine |
Life Sci |
1987 |
| Lamb RJ, Griffiths RR |
Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the ... |
Psychopharmacology (... |
1987 |
| Mokler DJ, Robinson SE, R... |
(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reduc... |
Eur J Pharmacol |
1987 |
| Noggle FT Jr, DeRuiter J,... |
Synthesis, identification, and acute toxicity of some N-alkyl derivati... |
J Assoc Off Anal Che... |
1987 |
| Peroutka SJ |
Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine... |
N Engl J Med |
1987 |
| Peroutka SJ, Pascoe N, Fa... |
Monoamine metabolites in the cerebralspinal fluid of recreational user... |
Research Comm in Sub... |
1987 |
| Ricaurte GA, Finnegan KF,... |
3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, pr... |
Eur J Pharmacol |
1987 |
| Rosecrans JA, Glennon RA |
The effect of MDA and MDMA ('Ecstasy') isomers in combination with pir... |
Pharmacol Biochem Be... |
1987 |
| Schechter MD |
MDMA as a discriminative stimulus: isomeric comparisons |
Pharmacol Biochem Be... |
1987 |
| Schmidt CJ |
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphet... |
J Pharmacol Exp Ther |
1987 |
| Smilkstein MJ, Smolinske ... |
A case of MAO inhibitor/MDMA interaction: agony after ecstasy |
J Toxicol Clin Toxic... |
1987 |
| Steele TD, Nichols DE, Yi... |
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and... |
Biochem Pharmacol |
1987 |
| Stone DM, Hanson GR, Gibb... |
Differences in the central serotonergic effects of methylenedioxymetha... |
Neuropharmacology |
1987 |
| Stone DM, Johnson M, Hans... |
A comparison of the neurotoxic potential of methylenedioxyamphetamine ... |
Eur J Pharmacol |
1987 |
| Stone DM, Merchant KM, Ha... |
Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... |
Neuropharmacology |
1987 |
| Thompson DM, Winsauer PJ,... |
Effects of phencyclidine, ketamine and MDMA on complex operant behavio... |
Pharmacol Biochem Be... |
1987 |
| Wang SS, Ricaurte GA, Per... |
[3H]3,4-methylenedioxymethamphetamine (MDMA) interactions with brain m... |
Eur J Pharmacol |
1987 |
| Finnegan KT, Ricaurte GA,... |
Orally administered MDMA causes a long-term depletion of serotonin in ... |
Brain Res |
1988 |
| Barnes DM |
Ecstasy returns to Schedule I |
Science |
1988 |
| Battaglia G, Brooks BP, K... |
Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at v... |
Eur J Pharmacol |
1988 |
| Battaglia G, Yeh SY, de S... |
MDMA-induced neurotoxicity: parameters of degeneration and recovery of... |
Pharmacol Biochem Be... |
1988 |
| Bost RO |
3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivat... |
J Forensic Sci |
1988 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Callahan PM, Appel JB |
Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... |
J Pharmacol Exp Ther |
1988 |
| Glennon RA, Yousif M, Pat... |
Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MD... |
Pharmacol Biochem Be... |
1988 |
| Gold LH, Koob GF |
Methysergide potentiates the hyperactivity produced by MDMA in rats |
Pharmacol Biochem Be... |
1988 |
| Hubner CB, Bird M, Rassni... |
The threshold lowering effects of MDMA (ecstasy) on brain-stimulation ... |
Psychopharmacology (... |
1988 |
| Johnson M, Hanson GR, Gib... |
Effects of dopaminergic and serotonergic receptor blockade on neuroche... |
Neuropharmacology |
1988 |
| Johnson M, Letter AA, Mer... |
Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... |
J Pharmacol Exp Ther |
1988 |
| Lim HK, Foltz RL |
In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine... |
Chem Res Toxicol |
1988 |
| Logan BJ, Laverty R, Sand... |
Differences between rats and mice in MDMA (methylenedioxymethylampheta... |
Eur J Pharmacol |
1988 |
| Mamounas LA, Molliver ME |
Evidence for dual serotonergic projections to neocortex: axons from th... |
Exp Neurol |
1988 |
| Nash JF Jr, Meltzer HY, G... |
Elevation of serum prolactin and corticosterone concentrations in the ... |
J Pharmacol Exp Ther |
1988 |
| Nencini P, Woolverton WL,... |
Enhancement of morphine-induced analgesia after repeated injections of... |
Brain Res |
1988 |
| Oberlender R, Nichols DE |
Drug discrimination studies with MDMA and amphetamine |
Psychopharmacology (... |
1988 |
